To further explore the physiological role of NF-κB activation on the development of hypertension in offspring of prenatal inflammatory stimulation, we used the inhibitor of IκBα degradation, PDTC, in vivo to block NF-κB activation simultaneously with LPS stimulation or postnatally in adulthood. Here, NFKBIA is linked to hypertensive disorder.